Percutaneous treatment in patients presenting with malignant cardiac tamponade

Marcy, Pierre-Yves; Bondiau, P.-Y.; Brunner, Philippe

doi:10.1007/s00330-004-2611-y

Cited by 17 publications

(5 citation statements)

References 29 publications

(45 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This intervention is tolerated with low morbidity and mortality also by patients with a poor performance status [14]. To achieve complete apposition of the parietal and visceral pericardium, an indwelling pericardial catheter can also be inserted for several days for extended drainage [15]. The efficacy of the insertion of these indwelling pericardial catheters has already been documented by Kopecky et al [16] in 1986 and was confirmed by following studies [14].…”

Section: Pericardial Effusionmentioning

confidence: 70%

Advanced Malignant Lung Disease: What the Specialist Can Offer

Gompelmann

Eberhardt

Herth³

2011

Respiration

View full text Add to dashboard Cite

Lung cancer is not only the most commonly diagnosed cancer worldwide, but it is still the leading cause for cancer-related death. The 5-year survival for lung cancer in Europe and in the USA is totally 16%. Therefore, a palliative therapy regimen is required to control the disease and reduce symptoms with the objective of enhancing quality of life of lung cancer patients. In addition to chemotherapy that is still one of the most important pillars in the treatment of advanced lung cancer, further interventional strategies can be offered to improve a patient’s quality of life. A locoregional tumour progression is frequently associated with malignant pleural effusion or pericardial effusion, central airway obstruction, tracheo-oesophageal fistula, severe haemoptysis or superior vena cava (SVC) syndrome threatening life and necessitating urgent palliation. Recurrent pleural effusion causing dyspnoea can be managed by pleurodesis, serial thoracocentesis or insertion of an indwelling catheter. Symptomatic malignant pericardial effusion often requires an urgent pericardiocentesis. Furthermore, surgical procedures, instillation of sclerosing agents or local chemotherapy should be considered in refractory pericardial effusion. The therapy regimen of central airway stenosis includes mechanical and thermic endoscopic procedures providing rapid relief of symptoms. To prevent recurrence of airway obstruction, the insertion of a stent or palliative brachytherapy provide re-establishment of the patency of obstructed airways. Haemoptysis can be managed by bronchoscopic interventions as well as by arterial embolization or palliative thoracic radiotherapy. The therapy of SVC syndrome is dependent of histology. In small-cell lung cancer, chemotherapy is recommended. In non-small-cell lung cancer, stent insertion and/or radiotherapy are the therapeutic pillars.

show abstract

Section: Pericardial Effusionmentioning

confidence: 70%

Advanced Malignant Lung Disease: What the Specialist Can Offer

Gompelmann

Eberhardt

Herth³

2011

Respiration

View full text Add to dashboard Cite

show abstract

“…To the best of our knowledge, the comparison of these three procedures has not been reported in a single study before, especially among patients with NSCLC. 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 Labbe et al. 27 retrospectively compared pericardiotomy and pericardiocentesis, and a higher recurrence rate was noted in the pericardiocentesis group.…”

Section: Discussionmentioning

confidence: 99%

“…Intervention procedures are crucial steps for preventing death due to pericardial tamponade, and different procedures show varying success rates, safety, and pericardial effusion recurrence rates. 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 Nowadays, simple pericardiocentesis, balloon pericardiotomy, or surgical pericardiectomy are often carried out on patients harboring symptomatic pericardial effusion. Pericardiocentesis is often carried out by pigtail insertion to the pericardial space, and it can be echo-guided, computed tomography-guided, or fluoroscopy-guided.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Recurrence of pericardial effusion after different procedure modalities in patients with non-small-cell lung cancer

Chang

Kuo

et al. 2022

ESMO Open

View full text Add to dashboard Cite

Background Lung cancer with related pericardial effusion is not rare. Intervention is a crucial step for symptomatic effusion. It is unknown, however, whether the different invasive interventions for pericardial effusion result in different survival outcomes. This study analyzed the clinical characteristics and prognostic factors for patients with non-small-cell lung cancer (NSCLC) who have undergone different procedures. Methods From January 2006 to June 2018, we collected data from patients with NSCLC who have received invasive intervention for pericardial effusions. The patients were divided into three categories: simple pericardiocentesis, balloon pericardiotomy, and surgical pericardiectomy. Kaplan–Meier curve and log-rank test were used to analyze the pericardial effusion recurrence-free survival (RFS) and overall survival (OS). Results A total of 244 patients were enrolled. Adenocarcinoma (83.6%) was the major NSCLC subtype. Invasive intervention, including simple pericardiocentesis, balloon pericardiotomy, and surgical pericardiectomy, had been carried out on 52, 170, and 22 patients, respectively. The 1-year RFS rates in simple pericardiocentesis, balloon pericardiotomy, and surgical pericardiectomy were 19.2%, 31.2%, and 31.8%, respectively ( P = 0.128), and the median RFS was 1.67, 5.03, and 8.32 months, respectively ( P = 0.008). There was no significant difference in OS, however, with the median OS at 1.67, 6.43, and 8.32 months, respectively ( P = 0.064). According to the multivariable analysis, the gravity in pericardial fluid analysis, receiving systemic therapy after pericardial effusion, and the time period from stage IV lung cancer to the presence of pericardial effusion were independent prognostic factors for pericardial effusion RFS and OS. Conclusions Patients who have undergone simple pericardiocentesis alone for the management of NSCLC-related pericardial effusion have lower 1-year RFS rates than those who have undergone balloon pericardiotomy and surgical pericardiectomy. Therefore, balloon pericardiotomy and surgical pericardiectomy should be carried out for patients with NSCLC-related pericardial effusion if tolerable.

show abstract

“…[12] Though the procedure was simple and effective, it is commonly associated with shunt thrombosis and recurrence of effusion. [1213] Olson et al .,[14] in their 11 years of experience with 33 patients, the surgical pericardioperitoneal window reported no mortality directly related to the pericardial effusion or the procedure. None of their patients developed peritoneal carcinomatosis or diaphragmatic hernia and only one patient developed recurrent pericardial effusion.…”

Section: Discussionmentioning

confidence: 99%

Pericardial-peritoneal window: A novel palliative treatment for malignant and recurrent cardiac tamponade

Kallianpur¹,

Samra²,

Nimbran³

et al. 2013

Indian J Palliat Care

View full text Add to dashboard Cite

Transdiaphragmatic approach to the pericardium through a subxiphoid incision is a safe, rapid, and effective way to obtain drainage of the pericardium fluid in patient of disseminated malignancy with recurrent cardiac tamponade. No drainage tubes are needed; pericardial fluid is absorbed by the peritoneum; there is no need for double lumen tubes for single lung ventilation and the subxiphoid incisions are small and almost painless.

show abstract

Percutaneous treatment in patients presenting with malignant cardiac tamponade

Cited by 17 publications

References 29 publications

Advanced Malignant Lung Disease: What the Specialist Can Offer

Advanced Malignant Lung Disease: What the Specialist Can Offer

Recurrence of pericardial effusion after different procedure modalities in patients with non-small-cell lung cancer

Pericardial-peritoneal window: A novel palliative treatment for malignant and recurrent cardiac tamponade

Contact Info

Product

Resources

About